JAK2 and renal fibrosis: Isoliquiritigenin reduced intercellular adhesion molecule‐1 and IL‐6 via inhibition of the JAK2/STAT3 pathway, relieving OS, renal fibrosis, and alleviating acute kidney injury in a diabetic rat model (Liu, Wang, Zhang, et al. 2023).